171 related articles for article (PubMed ID: 21709156)
1. Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.
Zhang J; Zhang Y; Dutta DJ; Argaw AT; Bonnamain V; Seto J; Braun DA; Zameer A; Hayot F; Lòpez CB; Raine CS; John GR
J Immunol; 2011 Aug; 187(3):1129-41. PubMed ID: 21709156
[TBL] [Abstract][Full Text] [Related]
2. IL-11 regulates autoimmune demyelination.
Gurfein BT; Zhang Y; López CB; Argaw AT; Zameer A; Moran TM; John GR
J Immunol; 2009 Oct; 183(7):4229-40. PubMed ID: 19734214
[TBL] [Abstract][Full Text] [Related]
3. Activation of oligodendroglial Stat3 is required for efficient remyelination.
Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.
Valerio A; Ferrario M; Dreano M; Garotta G; Spano P; Pizzi M
Mol Cell Neurosci; 2002 Dec; 21(4):602-15. PubMed ID: 12504593
[TBL] [Abstract][Full Text] [Related]
5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
6. Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Zhao C; Ma D; Zawadzka M; Fancy SP; Elis-Williams L; Bouvier G; Stockley JH; de Castro GM; Wang B; Jacobs S; Casaccia P; Franklin RJ
J Neurosci; 2015 Aug; 35(33):11482-99. PubMed ID: 26290228
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.
Kataria H; Alizadeh A; Shahriary GM; Saboktakin Rizi S; Henrie R; Santhosh KT; Thliveris JA; Karimi-Abdolrezaee S
Glia; 2018 Mar; 66(3):538-561. PubMed ID: 29148104
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
[TBL] [Abstract][Full Text] [Related]
9. Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury.
Chamberlain KA; Chapey KS; Nanescu SE; Huang JK
J Neurosci; 2017 Feb; 37(6):1479-1492. PubMed ID: 28069926
[TBL] [Abstract][Full Text] [Related]
10. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
11. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
12. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
13. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
Patel JR; Williams JL; Muccigrosso MM; Liu L; Sun T; Rubin JB; Klein RS
Acta Neuropathol; 2012 Dec; 124(6):847-60. PubMed ID: 22933014
[TBL] [Abstract][Full Text] [Related]
15. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
Tepavcević V; Blakemore WF
Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
[TBL] [Abstract][Full Text] [Related]
16. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
Garwood J; Garcion E; Dobbertin A; Heck N; Calco V; ffrench-Constant C; Faissner A
Eur J Neurosci; 2004 Nov; 20(10):2524-40. PubMed ID: 15548197
[TBL] [Abstract][Full Text] [Related]
17. PPAR-γ Is Critical for HDAC3-Mediated Control of Oligodendrocyte Progenitor Cell Proliferation and Differentiation after Focal Demyelination.
Ding L; Zhou J; Ye L; Sun Y; Jiang Z; Gan D; Xu L; Luo Q; Wang G
Mol Neurobiol; 2020 Nov; 57(11):4810-4824. PubMed ID: 32803489
[TBL] [Abstract][Full Text] [Related]
18. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon inhibits interleukin-1 production and inflammasome activation.
Guarda G; Braun M; Staehli F; Tardivel A; Mattmann C; Förster I; Farlik M; Decker T; Du Pasquier RA; Romero P; Tschopp J
Immunity; 2011 Feb; 34(2):213-23. PubMed ID: 21349431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
